Filter Results
:
(6)
Show Results For
- All HBS Web (11)
- Faculty Publications (4)
Show Results For
- All HBS Web (11)
- Faculty Publications (4)
Page 1 of
6
Results
Sort by
- July 2013
- Case
Novozymes: Establishing the Cellulosic Ethanol Value Chain
By: Willy Shih and Sen Chai
As the world's largest producer of industrial enzymes, Novozymes had invested heavily for many years to bio-engineer enzymes that could break down cellulose into fermentable sugar. In 2010, the company had launched what it thought would become a breakthrough product... View Details
Keywords:
System Complexity;
Industrial Enzymes;
Ethanol;
Collulosic Ethanol;
Fermentation;
Genomics;
Genetic Engineering;
Value Chain;
Assembling Value Chain;
Energy Sources;
Renewable Energy;
Collaborative Innovation and Invention;
Innovation and Management;
Innovation Strategy;
Technological Innovation;
Management;
Growth and Development Strategy;
Industry Growth;
Production;
Research;
Research and Development;
Science;
Genetics;
Natural Environment;
Environmental Sustainability;
Science-Based Business;
Business Strategy;
Commercialization;
Vertical Integration;
Agriculture and Agribusiness Industry;
Biotechnology Industry;
Energy Industry;
Denmark;
United States
Shih, Willy, and Sen Chai. "Novozymes: Establishing the Cellulosic Ethanol Value Chain." Harvard Business School Case 614-001, July 2013.
- April 2012
- Case
Novozymes: Cracking the Emerging Markets Code
By: Krishna G. Palepu and Karol Misztal
In 2011, the management of Novozymes, the industrial enzymes leader, reflected on the viability of their positioning in the fast growing, yet increasingly competitive Chinese market. Novozymes, a technological innovation pioneer, was prominent in China's premium enzyme...
View Details
Palepu, Krishna G., and Karol Misztal. "Novozymes: Cracking the Emerging Markets Code." Harvard Business School Case 112-084, April 2012.
- September 2003 (Revised March 2007)
- Case
Direvo Biotech AG
Describes the financing and growth decisions facing Direvo, a young German biotech firm with a customer/partner that wants to become an investor. Also discusses the business model for Direvo's directed evolution technology, with applications in both industrial enzymes...
View Details
Keywords:
Business Model;
Decisions;
Business Exit or Shutdown;
Value;
Business Startups;
Biotechnology Industry;
Germany
Roberts, Michael J., Vincent Dessain, and Anders Sjoman. "Direvo Biotech AG." Harvard Business School Case 804-017, September 2003. (Revised March 2007.)
- 22 May 2012
- First Look
First Look: May 22
supplement:http://cb.hbsp.harvard.edu/cb/product/512054-PDF-ENG Novozymes: Cracking the Emerging Markets Code Krishna G. Palepu and Karol MisztalHarvard Business School Case 112-084 In 2011, the management of Novozymes, the industrial...
View Details
Keywords:
Sean Silverthorne
- 24 Sep 2013
- First Look
First Look: September 24
Establishing the Cellulosic Ethanol Value Chain As the world's largest producer of industrial enzymes, Novozymes had invested heavily for many years to bio-engineer enzymes that could break down cellulose...
View Details
Keywords:
Sean Silverthorne